Determination of interleukin-4-responsive region in the human cytochrome P450 2E1 gene promoter

被引:24
作者
Abdel-Razzak, Z
Garlatti, M
Aggerbeck, M
Barouki, R
机构
[1] Univ Paris 05, UMRS, INSERM, Unit 490, F-75270 Paris 06, France
[2] Lebanese Univ, Fac Sci 1, Beirut, Lebanon
关键词
cytochrome P450 2E1; CYP2E1; interleukin-4; lnterleukin-1; beta; HepG2 cell line; signal transduction; transcription factors;
D O I
10.1016/j.bcp.2004.06.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cytochrome P450 2E1 (CYP2E1) gene expression is known to be induced by interleukin-4 (IL4) and repressed by inflammatory cytokines, such as interleukin-1beta3 (IL1beta3) in human hepatocytes. The mechanisms involved in these transcriptional regulations remain elusive. In order to study these mechanisms, various constructs of the human CYP2E1 promoter were prepared and transfected into the human HepG2 hepatoma cell line. Our findings revealed that an IL4-responsive region of 128 bp (-671/-544) was required to mediate induction by IL4. IL1beta caused moderate but significant decrease of the promoter activity, which was abolished when the two cytokines were combined. The IL1beta inhibitory effect is mediated through a regulatory sequence independent of that of IL4. Furthermore, by using specific signaling pathway inhibitors, we demonstrated that IL4 activation required protein kinase C (PKC) activation. In addition, our results suggest that induction by IL4 was not dependent on a single binding site but rather on a complex region which includes putative binding sites for signal transducer and activator of transcription (STAT)6, activator protein (AP)-1, nuclear factor kappa-B (NFkappaB), nuclear factor of activated T cells (NFAT) and CCAAT enhancer binding protein (C/EBP). Electrophoretic mobility shift assays suggest that AP1 and NFAT transcription factors are able to bind to three sites in the IL4-responsive region. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:1371 / 1381
页数:11
相关论文
共 60 条
[1]  
ABDELRAZZAK Z, 1993, MOL PHARMACOL, V44, P707
[2]   Down-regulation of interleukin-8 secretion from Mycobacterium tuberculosis-infected monocytes by interleukin-4 and-10 but not by interleukin-13 [J].
Ameixa, C ;
Friedland, JS .
INFECTION AND IMMUNITY, 2001, 69 (04) :2470-2476
[3]  
BANCHEREAU J, 1991, B CANCER, V78, P299
[4]   IL-4 and IL-13 receptors: Are they one and the same? [J].
Callard, RE ;
Matthews, DJ ;
Hibbert, L .
IMMUNOLOGY TODAY, 1996, 17 (03) :108-110
[5]   A LIVER-SPECIFIC FACTOR ESSENTIAL FOR ALBUMIN TRANSCRIPTION DIFFERS BETWEEN DIFFERENTIATED AND DEDIFFERENTIATED RAT HEPATOMA-CELLS [J].
CEREGHINI, S ;
BLUMENFELD, M ;
YANIV, M .
GENES & DEVELOPMENT, 1988, 2 (08) :957-974
[6]   NFAT signaling: Choreographing the social lives of cells [J].
Crabtree, GR ;
Olson, EN .
CELL, 2002, 109 :S67-S79
[7]   Induction of the IL-13 receptor α2-chain by IL-4 and IL-13 in human keratinocytes:: involvement of STAT6, ERK and p38 MAPK pathways [J].
David, M ;
Ford, D ;
Bertoglio, J ;
Maizel, AL ;
Pierre, J .
ONCOGENE, 2001, 20 (46) :6660-6668
[8]   CHARACTERIZATION OF AN INTERLEUKIN-4 (IL-4) RESPONSIVE REGION IN THE IMMUNOGLOBULIN HEAVY-CHAIN GERMLINE EPSILON-PROMOTER - REGULATION BY NF-IL-4, A C/EBP FAMILY MEMBER AND NF-KAPPA-B-P50 [J].
DELPHIN, S ;
STAVNEZER, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (01) :181-192
[9]   THE EFFECTS OF INDUCING AGENTS ON CYTOCHROME-P450 AND UDP-GLUCURONOSYLTRANSFERASE ACTIVITIES IN HUMAN HEPG2 HEPATOMA-CELLS [J].
DOOSTDAR, H ;
GRANT, MH ;
MELVIN, WT ;
WOLF, CR ;
BURKE, MD .
BIOCHEMICAL PHARMACOLOGY, 1993, 46 (04) :629-635
[10]   Unusual interleukin-4 and-13 signaling in human normal and tumor lung fibroblasts [J].
Doucet, C ;
Jasmin, C ;
Azzarone, B .
ONCOGENE, 2000, 19 (51) :5898-5905